Colon Cancer Prevention

2

Review clinical trials related to Colon Cancer Prevention. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Delayed Surveillance Colonoscopy Following Piecemeal EMR

This multicenter, prospective, randomized non inferiority trial, conducted at four Israeli hospitals, will evaluate whether a relaxed surveillance strategy after piecemeal endoscopic mucosal resection (pEMR) of large non pedunculated colorectal polyps (LNPCPs, ≥20 mm) is as safe and effective as the current standard intensive surveillance. Approximately 760 adults undergoing complete pEMR with margin ablation will be randomized 1:1 into: Standard Surveillance: Colonoscopy at 6, 18, and 48 months Relaxed Surveillance: Colonoscopy at 12 and 48 months All colonoscopies will be performed using high definition white light and narrow band imaging, with biopsies obtained only if recurrence is suspected. The investigators hypothesize that a relaxed surveillance strategy will be non inferior to the current standard intensive surveillance. If non inferiority is demonstrated, the study may support guideline changes toward reduced surveillance frequency after pEMR with margin ablation, potentially decreasing patient burden and healthcare costs.

Participants needed: 760
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Rambam Health Care CampusUpdated: Jan 9, 2026Locations: 1
Eligibility criteria

Adults aged 18 years and older [+2]

Patients with invasive cancer identified during the index procedure [+3]

Status: Recruiting

Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity

This is a multicenter, non-pharmacological, experimental, prospective, randomized study, with two arms (1:1) in a single-blind design. The study aims to evaluate the effectiveness of a tele-consultation procedure in patients undergoing elective colonoscopy in terms of quality of the exam, anxiety procedure-related and financial toxicity.

Participants needed: 534
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: National Cancer Institute, NaplesUpdated: Mar 26, 2025Locations: 1
Eligibility criteria

for diagnostic purposes; [+4]

Patients under 18 years of age or over 80 years of age; [+9]